Literature DB >> 6851301

Muscle in chronic uremia--a histochemical and morphometric study of human quadriceps muscle biopsies.

A J Shah, V Sahgal, A P Quintanilla, V Subramani, H Singh, R Hughes.   

Abstract

This report describes qualitative and quantitative studies performed on ten muscle biopsies from chronic uremic patients on renal dialysis at light and electron microscopic (EM) levels. The muscle biopsies showed myopathic changes (variation in fiber size, central nuclei, and fiber splitting). Histochemical studies showed type II fiber atrophy and lipid deposits. The ultrastructural study showed disruption of myofibrillary architecture and subsarcolemmal deposits of glycogen, mitochondria, and lipids. Quantitative estimations of the subcellular organelles revealed a statistically significant increase in lipid and glycogen contents of the muscle. The myopathic changes, type II atrophy, and lipid and glycogen deposits in chronic uremic patients raise the question of the effects of uremia and/or chronic dialysis on muscle metabolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6851301

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  12 in total

1.  Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice.

Authors:  Ping Li; Richard E Waters; Shelley I Redfern; Mei Zhang; Lan Mao; Brian H Annex; Zhen Yan
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

2.  Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients.

Authors:  Michael I Lewis; Mario Fournier; Huiyuan Wang; Thomas W Storer; Richard Casaburi; Arthur H Cohen; Joel D Kopple
Journal:  J Appl Physiol (1985)       Date:  2011-10-20

3.  Optimized in-phase and opposed-phase MR imaging for accurate detection of small fat or water fractions: theoretical considerations and experimental application in emulsions.

Authors:  Verena Ballweg; Hanne Wojtczyk; Nadine Roth; Petros Martirosian; Fabian Springer; Fritz Schick
Journal:  MAGMA       Date:  2011-03-27       Impact factor: 2.310

4.  Impact of physical training on the ultrastructure of midthigh muscle in normal subjects and in patients treated with glucocorticoids.

Authors:  F F Horber; H Hoopeler; J R Scheidegger; B E Grünig; H Howald; F J Frey
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

Review 5.  Reactive Oxygen Species/Nitric Oxide Mediated Inter-Organ Communication in Skeletal Muscle Wasting Diseases.

Authors:  Lucia M Leitner; Rebecca J Wilson; Zhen Yan; Axel Gödecke
Journal:  Antioxid Redox Signal       Date:  2017-01-04       Impact factor: 8.401

6.  PGC-1α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice.

Authors:  Tuoyu Geng; Ping Li; Xinhe Yin; Zhen Yan
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

Review 7.  Morphological, electrophysiological, and metabolic characteristics of skeletal muscle in people with end-stage renal disease: a critical review.

Authors:  Anuradha Sawant; S Jayne Garland; Andrew A House; Tom J Overend
Journal:  Physiother Can       Date:  2011-08-10       Impact factor: 1.037

8.  Skeletal muscle fibrosis is associated with decreased muscle inflammation and weakness in patients with chronic kidney disease.

Authors:  Matthew K Abramowitz; William Paredes; Kehao Zhang; Camille R Brightwell; Julia N Newsom; Hyok-Joon Kwon; Matthew Custodio; Rupinder S Buttar; Hina Farooq; Bushra Zaidi; Rima Pai; Jeffrey E Pessin; Meredith Hawkins; Christopher S Fry
Journal:  Am J Physiol Renal Physiol       Date:  2018-10-03

9.  Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease.

Authors:  Jorge L Gamboa; Frederic T Billings; Matthew T Bojanowski; Laura A Gilliam; Chang Yu; Baback Roshanravan; L Jackson Roberts; Jonathan Himmelfarb; T Alp Ikizler; Nancy J Brown
Journal:  Physiol Rep       Date:  2016-05

10.  Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuli.

Authors:  Zengli Yu; Ping Li; Mei Zhang; Mark Hannink; Jonathan S Stamler; Zhen Yan
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.